Phreesia Inc (0A23.L) Q2 2026 Earnings Report

Comprehensive analysis of Phreesia Inc's financial performance for Q2 2026 with historical comparisons and future outlook.

Previous: Q1 2026
Phreesia Inc
0A23.L
$28.50 -1.96%
Exchange: LSE | Sector: Healthcare | Industry: Medical Equipment Services
Q2 2026
Published: Sep 5, 2025

Earnings Highlights

  • Revenue of $117.26M up 14.8% year-over-year
  • EPS of $0.01 increased by 103.6% from previous year
  • Gross margin of 103.4%
  • Net income of 654.00K
  • "N/A" - N/A

Phreesia Inc (0A23.L) QQ2 2026 Results — Healthy Growth, Positive Operating Leverage, and Strong Liquidity in Healthcare SaaS

Executive Summary

Phreesia Inc delivered a solid QQ2 2026 performance, underpinned by ongoing demand for its SaaS-based patient intake and payments platform. Revenue of USD 117.3 million represented a YoY increase of approximately 14.8% and a modest sequential uptick of about 1.1%, with operating income of USD 26.15 million and a double-digit operating margin (~22.3%). EBITDA was positive at USD 6.85 million (EBITDA margin ~5.8%), and net income reached USD 0.654 million with EPS of USD 0.011. The quarter also demonstrated robust cash generation, with operating cash flow of USD 14.84 million and free cash flow of USD 13.07 million. The company ended the period with USD 98.27 million in cash and equivalents and a net debt position of USD -93.51 million, reflecting a strong liquidity profile and limited net leverage.

Key Performance Indicators

Revenue

117.26M
QoQ: 1.14% | YoY:14.83%

Gross Profit

121.29M
1.03% margin
QoQ: 55.75% | YoY:96.23%

Operating Income

26.15M
QoQ: 895.41% | YoY:251.81%

Net Income

654.00K
QoQ: 116.71% | YoY:103.63%

EPS

0.01
QoQ: 116.57% | YoY:103.55%

Revenue Trend

Margin Analysis

Key Insights

Revenue: USD 117.255M; YoY +14.83%; QoQ +1.14%. Gross Profit: YoY +96.23%; QoQ +55.75% (based on reported metrics; gross profit margin indications are elevated by the dataset). EBITDA: USD 6.845M; EBITDA margin ~5.8% (EBITDA/Revenue). Operating Income: USD 26.145M; Operating Margin ~22.3%. Net Income: USD 0.654M; Net Margin ~0.56%. EPS: USD 0.011 (basic); USD 0.0106 (diluted). Operating Cash Flow: USD 14.835M. Free Cash Flow: USD 13.068M. Capex: USD -1.767M. Net Change in Cash: USD 7.395M; Cash ...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2026 117.26 0.01 +14.8% View
Q1 2026 115.94 -0.07 +14.5% View
Q4 2025 109.68 -0.11 +15.5% View
Q3 2025 106.80 0.65 +16.6% View
Q2 2025 102.12 -0.31 +19.0% View

More 0A23.L Quarterly Reports

0A23.L

Phreesia Inc
Q1 2026 Report
Phreesia Inc (0A23.L) QQ1 2026 Earnings Analysis — Revenue Growth with Positive Cash Flow Amid Near-Term Profitability Challenges...
Read full report

0A23.L

Phreesia Inc
Q4 2025 Report
Phreesia Inc (0A23.L) QQ4 2025 Results – Solid gross margins and positive cash flow amid ongoing investment phase...
Read full report

0A23.L

Phreesia Inc
Q3 2025 Report
Phreesia Inc (0A23.L) QQ3 2025 Results – Durable SaaS Platform Delivers Revenue Growth with Near-Term Profitability Headwinds...
Read full report

0A23.L

Phreesia Inc
Q2 2025 Report
Phreesia Inc (0A23.L) QQ2 2025 Results – Revenue Growth in a Cash-Rich SaaS Model with Near-Term Losses...
Read full report

Related Financial Data

Sector Analysis: Healthcare

View more companies and financial data in the Healthcare sector.

Explore Sector

0A23.L Full Profile

View complete financial profile, news, and analysis for Phreesia Inc.

Company Profile

0A23.L Financial Statements

Access detailed balance sheets, income statements, and cash flow reports.

View Financials

Earnings Calendar

Stay updated with upcoming earnings announcements from all public companies.

View Calendar